PROSIGHT MANAGEMENT, LP Holdings

PROSIGHT MANAGEMENT, LP is an investment fund managing more than 186.66M US dollars. The largest holdings include Prothena Corporation, Horizon Therapeutics Public Limited Company and Galapagos NV. In Q3 2022 the fund bought assets of total value of 66.57M US dollars and sold assets of total value of 8.09M US dollars.

$186.65M

portfolio value

+25.31%

quarter

-17.25%

1 year

+72.64%

3 years

PROSIGHT MANAGEMENT, LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2018	62237000	43184000
Q2 2018	27018000	51413000
Q3 2018	71647000	25896000
Q4 2018	50479000	37707000
Q1 2019	63683000	28284000
Q2 2019	51607000	55132000
Q3 2019	28920000	40022000
Q4 2019	75221000	33761000
Q1 2020	56226000	52674000
Q2 2020	48920000	62434000
Q3 2020	55672000	52446000
Q4 2020	59437000	63473000
Q1 2021	32247000	108417000
Q2 2021	58758000	22985000
Q3 2021	47567000	36365000
Q4 2021	32526000	53722000
Q1 2022	25374000	23431000
Q2 2022	29022000	47634000
Q3 2022	66566000	8089000

PROSIGHT MANAGEMENT, LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Prothena Corporation plc Portfolio share: 10.43% Portfolio value: 19.46M Avg. open price: $25.12 Current price: $60.39 P/L: +140.37% Sold -41.62% shares Q3 2022	share	10.43%	19.46M	$25.12	$60.39	+140.37%	Sold -41.62% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 10.05% Portfolio value: 18.75M Avg. open price: N/A Current price: $98.48 P/L: N/A N/A Q3 2022	share	10.05%	18.75M	N/A	$98.48	N/A	N/A Q3 2022
Biotechnology Galapagos NV Portfolio share: 9.25% Portfolio value: 17.26M Avg. open price: $62.04 Current price: $38.92 P/L: -37.27% Bought +9.76% shares Q3 2022	share	9.25%	17.26M	$62.04	$38.92	-37.27%	Bought +9.76% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 6.13% Portfolio value: 11.43M Avg. open price: $13.99 Current price: $7.07 P/L: -49.46% Bought +5.16% shares Q3 2022	share	6.13%	11.43M	$13.99	$7.07	-49.46%	Bought +5.16% shares Q3 2022
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 6.01% Portfolio value: 11.21M Avg. open price: N/A Current price: $25.51 P/L: N/A N/A Q3 2022	share	6.01%	11.21M	N/A	$25.51	N/A	N/A Q3 2022
Biotechnology Albireo Pharma, Inc. Portfolio share: 5.09% Portfolio value: 9.51M Avg. open price: $32.28 Current price: $22.7 P/L: -29.67% Bought +5.01% shares Q3 2022	share	5.09%	9.51M	$32.28	$22.7	-29.67%	Bought +5.01% shares Q3 2022
Biotechnology MeiraGTx Holdings plc Portfolio share: 4.97% Portfolio value: 9.27M Avg. open price: $13.83 Current price: $6.49 P/L: -53.12% Bought +11.88% shares Q3 2022	share	4.97%	9.27M	$13.83	$6.49	-53.12%	Bought +11.88% shares Q3 2022
Biotechnology KalVista Pharmaceuticals, Inc. Portfolio share: 4.12% Portfolio value: 7.69M Avg. open price: $16.16 Current price: $5.17 P/L: -68.00% Sold -35.42% shares Q3 2022	share	4.12%	7.69M	$16.16	$5.17	-68.00%	Sold -35.42% shares Q3 2022
Diagnostics & Research Charles River Laboratories International, Inc. Portfolio share: 3.50% Portfolio value: 6.53M Avg. open price: $333.28 Current price: $215.11 P/L: -35.46% Bought +20.80% shares Q3 2022	share	3.50%	6.53M	$333.28	$215.11	-35.46%	Bought +20.80% shares Q3 2022
Biotechnology Aldeyra Therapeutics, Inc. Portfolio share: 3.46% Portfolio value: 6.46M Avg. open price: $6.45 Current price: $6.46 P/L: +0.12% Sold -39.03% shares Q3 2022	share	3.46%	6.46M	$6.45	$6.46	+0.12%	Sold -39.03% shares Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 3.33% Portfolio value: 6.21M Avg. open price: N/A Current price: $547.42 P/L: N/A N/A Q3 2022	share	3.33%	6.21M	N/A	$547.42	N/A	N/A Q3 2022
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 3.21% Portfolio value: 5.98M Avg. open price: $20.52 Current price: $18.33 P/L: -10.68% Bought +76.44% shares Q3 2022	share	3.21%	5.98M	$20.52	$18.33	-10.68%	Bought +76.44% shares Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 2.82% Portfolio value: 5.26M Avg. open price: $52.56 Current price: $44.6 P/L: -15.14% Bought +101.18% shares Q3 2022	share	2.82%	5.26M	$52.56	$44.6	-15.14%	Bought +101.18% shares Q3 2022
Drug Manufacturers—General Johnson & Johnson Portfolio share: 2.77% Portfolio value: 5.17M Avg. open price: N/A Current price: $178.78 P/L: N/A N/A Q3 2022	share	2.77%	5.17M	N/A	$178.78	N/A	N/A Q3 2022
Medical Instruments & Supplies QuidelOrtho Corporation Portfolio share: 2.41% Portfolio value: 4.49M Avg. open price: $97.18 Current price: $93.6 P/L: -3.68% Bought +35.05% shares Q3 2022	share	2.41%	4.49M	$97.18	$93.6	-3.68%	Bought +35.05% shares Q3 2022
Biotechnology Cue Biopharma, Inc. Portfolio share: 1.85% Portfolio value: 3.44M Avg. open price: $14.95 Current price: $3.57 P/L: -76.11% Sold -6.64% shares Q3 2022	share	1.85%	3.44M	$14.95	$3.57	-76.11%	Sold -6.64% shares Q3 2022
Biotechnology Prothena Corporation plc Portfolio share: 1.72% Portfolio value: 3.21M Avg. open price: $25.12 Current price: $60.39 P/L: +140.37% N/A Q3 2022	call	1.72%	3.21M	$25.12	$60.39	+140.37%	N/A Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 1.71% Portfolio value: 3.19M Avg. open price: $19.42 Current price: $19.03 P/L: -2.01% Sold -27.75% shares Q3 2022	share	1.71%	3.19M	$19.42	$19.03	-2.01%	Sold -27.75% shares Q3 2022
Biotechnology Shattuck Labs, Inc. Portfolio share: 1.62% Portfolio value: 3.02M Avg. open price: $8.26 Current price: $2.28 P/L: -72.39% Bought +9.88% shares Q3 2022	share	1.62%	3.02M	$8.26	$2.28	-72.39%	Bought +9.88% shares Q3 2022
Biotechnology ORIC Pharmaceuticals, Inc. Portfolio share: 1.61% Portfolio value: 2.99M Avg. open price: N/A Current price: $4.02 P/L: N/A N/A Q3 2022	share	1.61%	2.99M	N/A	$4.02	N/A	N/A Q3 2022
Biotechnology Incyte Corporation Portfolio share: 1.44% Portfolio value: 2.69M Avg. open price: N/A Current price: $84.08 P/L: N/A N/A Q3 2022	share	1.44%	2.69M	N/A	$84.08	N/A	N/A Q3 2022
Health Information Services Omnicell, Inc. Portfolio share: 1.43% Portfolio value: 2.67M Avg. open price: N/A Current price: $49.45 P/L: N/A N/A Q3 2022	share	1.43%	2.67M	N/A	$49.45	N/A	N/A Q3 2022
Specialty Chemicals Avantor, Inc. Portfolio share: 1.29% Portfolio value: 2.40M Avg. open price: N/A Current price: $22.35 P/L: N/A N/A Q3 2022	share	1.29%	2.40M	N/A	$22.35	N/A	N/A Q3 2022
Medical Instruments & Supplies Baxter International Inc. Portfolio share: 1.13% Portfolio value: 2.10M Avg. open price: $84.42 Current price: $51.3 P/L: -39.23% N/A Q3 2022	share	1.13%	2.10M	$84.42	$51.3	-39.23%	N/A Q3 2022
Biotechnology Rhythm Pharmaceuticals, Inc. Portfolio share: 1.05% Portfolio value: 1.96M Avg. open price: N/A Current price: $27.14 P/L: N/A N/A Q3 2022	share	1.05%	1.96M	N/A	$27.14	N/A	N/A Q3 2022
Health Information Services 1Life Healthcare, Inc. Portfolio share: 0.98% Portfolio value: 1.82M Avg. open price: N/A Current price: $16.74 P/L: N/A Sold -85.35% shares Q3 2022	share	0.98%	1.82M	N/A	$16.74	N/A	Sold -85.35% shares Q3 2022
Biotechnology Cassava Sciences, Inc. Portfolio share: 0.80% Portfolio value: 1.50M Avg. open price: N/A Current price: $33.74 P/L: N/A N/A Q3 2022	put	0.80%	1.50M	N/A	$33.74	N/A	N/A Q3 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 0.77% Portfolio value: 1.43M Avg. open price: N/A Current price: $11.58 P/L: N/A Sold -35.59% shares Q3 2022	share	0.77%	1.43M	N/A	$11.58	N/A	Sold -35.59% shares Q3 2022
Biotechnology Ardelyx, Inc. Portfolio share: 0.72% Portfolio value: 1.34M Avg. open price: N/A Current price: $1.86 P/L: N/A Sold -47.95% shares Q3 2022	share	0.72%	1.34M	N/A	$1.86	N/A	Sold -47.95% shares Q3 2022
Drug Manufacturers—Specialty & Generic Evolus, Inc. Portfolio share: 0.69% Portfolio value: 1.29M Avg. open price: $13.28 Current price: $6.98 P/L: -47.43% N/A Q3 2022	share	0.69%	1.29M	$13.28	$6.98	-47.43%	N/A Q3 2022
Biotechnology ProQR Therapeutics N.V. Portfolio share: 0.68% Portfolio value: 1.27M Avg. open price: $2.72 Current price: $1.41 P/L: -48.20% Bought +0.51% shares Q3 2022	share	0.68%	1.27M	$2.72	$1.41	-48.20%	Bought +0.51% shares Q3 2022
Biotechnology ADC Therapeutics SA Portfolio share: 0.64% Portfolio value: 1.19M Avg. open price: N/A Current price: $3.52 P/L: N/A N/A Q3 2022	share	0.64%	1.19M	N/A	$3.52	N/A	N/A Q3 2022
Biotechnology Graphite Bio, Inc. Portfolio share: 0.61% Portfolio value: 1.13M Avg. open price: N/A Current price: $3.59 P/L: N/A N/A Q3 2022	share	0.61%	1.13M	N/A	$3.59	N/A	N/A Q3 2022
Biotechnology Silverback Therapeutics, Inc. Portfolio share: 0.56% Portfolio value: 1.03M Avg. open price: $6.43 Current price: $5.87 P/L: -8.72% Sold -42.46% shares Q3 2022	share	0.56%	1.03M	$6.43	$5.87	-8.72%	Sold -42.46% shares Q3 2022
Biotechnology AbCellera Biologics Inc. Portfolio share: 0.46% Portfolio value: 856K Avg. open price: N/A Current price: $11.91 P/L: N/A N/A Q3 2022	share	0.46%	856K	N/A	$11.91	N/A	N/A Q3 2022
Health Information Services R1 RCM Inc. Portfolio share: 0.32% Portfolio value: 595K Avg. open price: N/A Current price: $10.11 P/L: N/A N/A Q3 2022	share	0.32%	595K	N/A	$10.11	N/A	N/A Q3 2022
Health Information Services Spok Holdings, Inc. Portfolio share: 0.27% Portfolio value: 497K Avg. open price: N/A Current price: $7.82 P/L: N/A N/A Q3 2022	share	0.27%	497K	N/A	$7.82	N/A	N/A Q3 2022
Biotechnology Maravai LifeSciences Holdings, Inc. Portfolio share: 0.12% Portfolio value: 218K Avg. open price: N/A Current price: $13.34 P/L: N/A N/A Q3 2022	share	0.12%	218K	N/A	$13.34	N/A	N/A Q3 2022
Health Information Services 1Life Healthcare, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $16.74 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$16.74	N/A	Sold -100.00% shares Q3 2022
Biotechnology Global Blood Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $68.49 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$68.49	N/A	Sold -100.00% shares Q3 2022
Biotechnology Cognition Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.67 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.67	N/A	Sold -100.00% shares Q3 2022
Medical Devices InMode Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $36.66 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$36.66	N/A	Sold -100.00% shares Q3 2022
Medical Devices Apollo Endosurgery, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $2.67 Current price: $9.99 P/L: +274.15% Sold -100.00% shares Q3 2022	share	0.00%	0	$2.67	$9.99	+274.15%	Sold -100.00% shares Q3 2022

Showing TOP 43 PROSIGHT MANAGEMENT, LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of PROSIGHT MANAGEMENT, LP?

The biggest position of the PROSIGHT MANAGEMENT, LP is Prothena Corporation plc (PRTA) with 10.43% portfolio share worth of 19.47M US dollars.

Top 5 PROSIGHT MANAGEMENT, LP's holdings represent 41.86% of the portfolio:

Prothena Corporation plc (PRTA) – 10.43%
Horizon Therapeutics Public Limited Company (HZNP) – 10.05%
Galapagos NV (GLPG) – 9.25%
Kezar Life Sciences, Inc. (KZR) – 6.13%
Alkermes plc (ALKS) – 6.01%

Who is the portfolio manager of PROSIGHT MANAGEMENT, LP?

The portfolio manager of the PROSIGHT MANAGEMENT, LP is .

What is the total asset value of the PROSIGHT MANAGEMENT, LP portfolio?

PROSIGHT MANAGEMENT, LP total asset value (portfolio value) is 186.66M US dollars.

Who is ?

is the portfolio manager of the PROSIGHT MANAGEMENT, LP.

What is (PROSIGHT MANAGEMENT, LP) fund performance?

PROSIGHT MANAGEMENT, LP's quarterly performance is +25.31%, annualy -17.25%. In the past 3 years, the value of 's portfolio has increased by +73%.

What is the PROSIGHT MANAGEMENT, LP CIK?

PROSIGHT MANAGEMENT, LP's Central Index Key is 0001617201 .